Empire Financial Management Company »

Novartis shares owned by Empire Financial Management Company

Quarter-by-quarter ownership of Novartis (NVS) shares owned by Empire Financial Management Company from 13F filings

Historical chart of Empire Financial Management Company investment in Novartis

Tip: Access up to 7 years of quarterly data

All positions including Novartis held by Empire Financial Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novartis by Empire Financial Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.0M 10k 100.98
2023-09-30 $1.0M 10k 101.87
2023-06-30 $1.0M 10k 100.92
2023-03-31 $965k 11k 92.01

More positions owned by Empire Financial Management Company

Etf Series Solutions Distillate Us (DSTL)
Microsoft Corporation (MSFT)
Apple (AAPL)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Litman Gregory Funds Trust Imgp Dbi Managed (DBMF)
Alphabet Cap Stk Cl A (GOOGL)
International Business Machines (IBM)
Pacer Fds Tr Globl Cash Etf (GCOW)
Abbott Laboratories (ABT)
Etf Series Solutions Distillate Intnl (DSTX)
John Hancock Exchange Traded Multifactr Sml (JHSC)
Procter & Gamble Company (PG)
Home Depot (HD)
Ea Ser Tr Marketdesk Focus (FDIV)

View all positions for Empire Financial Management Company

Top funds holding Novartis

Dodge & Cox
PRIMECAP Management Company
Morgan Stanley
Dimensional Fund Advisors
Loomis, Sayles and
Franklin Resources
Bank of America Corporation
Wellington Management Company
Goldman Sachs Group
Cullen Capital Management
Henderson Group
Principal Financial Group
Northern Trust
Mondrian Investment Partners
Wells Fargo & Company

View all funds holding Novartis